Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

U S Physical Therapy (USPH) Shares Outstanding (Weighted Average) (2016 - 2025)

U S Physical Therapy's Shares Outstanding (Weighted Average) history spans 11 years, with the latest figure at $13.0 million for Q4 2022.

  • For Q4 2022, Shares Outstanding (Weighted Average) rose 0.67% year-over-year to $13.0 million; the TTM value through Dec 2022 reached $13.0 million, up 0.67%, while the annual FY2022 figure was $13.0 million, 0.67% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2022 was $13.0 million at U S Physical Therapy, roughly flat from $13.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $13.0 million in Q4 2022 and bottomed at $12.6 million in Q1 2018.
  • The 5-year median for Shares Outstanding (Weighted Average) is $12.8 million (2020), against an average of $12.8 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 0.83% in 2018 before it rose 0.42% in 2020.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $12.7 million in 2018, then rose by 0.71% to $12.8 million in 2019, then grew by 0.62% to $12.8 million in 2020, then grew by 0.49% to $12.9 million in 2021, then increased by 0.67% to $13.0 million in 2022.
  • Per Business Quant, the three most recent readings for USPH's Shares Outstanding (Weighted Average) are $13.0 million (Q4 2022), $13.0 million (Q2 2022), and $12.9 million (Q1 2022).